BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 1490382)

  • 21. Sp1 cooperates with c-Myc to activate transcription of the human telomerase reverse transcriptase gene (hTERT).
    Kyo S; Takakura M; Taira T; Kanaya T; Itoh H; Yutsudo M; Ariga H; Inoue M
    Nucleic Acids Res; 2000 Feb; 28(3):669-77. PubMed ID: 10637317
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overexpression of Mxi1 inhibits the induction of the human ornithine decarboxylase gene by the Myc/Max protein complex.
    Wu S; Peña A; Korcz A; Soprano DR; Soprano KJ
    Oncogene; 1996 Feb; 12(3):621-9. PubMed ID: 8637719
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oncogenic activity of the c-Myc protein requires dimerization with Max.
    Amati B; Brooks MW; Levy N; Littlewood TD; Evan GI; Land H
    Cell; 1993 Jan; 72(2):233-45. PubMed ID: 8425220
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reconstitution of an E box-binding Myc:Max complex with recombinant full-length proteins expressed in Escherichia coli.
    Farina A; Faiola F; Martinez E
    Protein Expr Purif; 2004 Apr; 34(2):215-22. PubMed ID: 15003254
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mxi1, a protein that specifically interacts with Max to bind Myc-Max recognition sites.
    Zervos AS; Gyuris J; Brent R
    Cell; 1993 Jan; 72(2):223-32. PubMed ID: 8425219
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cell density and paradoxical transcriptional properties of c-Myc and Max in cultured mouse fibroblasts.
    Lee LA; Resar LM; Dang CV
    J Clin Invest; 1995 Feb; 95(2):900-4. PubMed ID: 7860774
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Myc and Max proteins possess distinct transcriptional activities.
    Kretzner L; Blackwood EM; Eisenman RN
    Nature; 1992 Oct; 359(6394):426-9. PubMed ID: 1406956
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Myc-Max heterodimers activate a DEAD box gene and interact with multiple E box-related sites in vivo.
    Grandori C; Mac J; Siëbelt F; Ayer DE; Eisenman RN
    EMBO J; 1996 Aug; 15(16):4344-57. PubMed ID: 8861962
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A dominant-negative mutant of Max that inhibits sequence-specific DNA binding by Myc proteins.
    Billaud M; Isselbacher KJ; Bernards R
    Proc Natl Acad Sci U S A; 1993 Apr; 90(7):2739-43. PubMed ID: 8464883
    [TBL] [Abstract][Full Text] [Related]  

  • 30. myc, max, and a novel rlf-L-myc fusion protein in small-cell lung cancer.
    Västrik I; Mäkelä TP; Koskinen PJ; Saksela K; Alitalo K
    Princess Takamatsu Symp; 1991; 22():307-18. PubMed ID: 1668890
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of casein kinase II phosphorylation sites in Max: effects on DNA-binding kinetics of Max homo- and Myc/Max heterodimers.
    Bousset K; Henriksson M; Lüscher-Firzlaff JM; Litchfield DW; Lüscher B
    Oncogene; 1993 Dec; 8(12):3211-20. PubMed ID: 8247525
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discrimination between different E-box-binding proteins at an endogenous target gene of c-myc.
    Desbarats L; Gaubatz S; Eilers M
    Genes Dev; 1996 Feb; 10(4):447-60. PubMed ID: 8600028
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determination of binding constant of transcription factor myc-max/max-max and E-box DNA: the effect of inhibitors on the binding.
    Park S; Chung S; Kim KM; Jung KC; Park C; Hahm ER; Yang CH
    Biochim Biophys Acta; 2004 Feb; 1670(3):217-28. PubMed ID: 14980448
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gene-regulatory properties of Myc helix-loop-helix/leucine zipper mutants: Max-dependent DNA binding and transcriptional activation in yeast correlates with transforming capacity.
    Crouch DH; Fisher F; Clark W; Jayaraman PS; Goding CR; Gillespie DA
    Oncogene; 1993 Jul; 8(7):1849-55. PubMed ID: 8510929
    [TBL] [Abstract][Full Text] [Related]  

  • 35. c-Myc/Max heterodimers bind cooperatively to the E-box sequences located in the first intron of the rat ornithine decarboxylase (ODC) gene.
    Walhout AJ; Gubbels JM; Bernards R; van der Vliet PC; Timmers HT
    Nucleic Acids Res; 1997 Apr; 25(8):1493-501. PubMed ID: 9162900
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Max transcription factor network: involvement of Mad in differentiation and an approach to identification of target genes.
    Hurlin PJ; Ayer DE; Grandori C; Eisenman RN
    Cold Spring Harb Symp Quant Biol; 1994; 59():109-16. PubMed ID: 7587059
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The mycN/max protein complex in neuroblastoma. Short review.
    Wenzel A; Schwab M
    Eur J Cancer; 1995; 31A(4):516-9. PubMed ID: 7576956
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Myc family oncoproteins function through a common pathway to transform normal cells in culture: cross-interference by Max and trans-acting dominant mutants.
    Mukherjee B; Morgenbesser SD; DePinho RA
    Genes Dev; 1992 Aug; 6(8):1480-92. PubMed ID: 1644290
    [TBL] [Abstract][Full Text] [Related]  

  • 39. c-Myc does not require max for transcriptional activity in PC-12 cells.
    Ribon V; Leff T; Saltiel AR
    Mol Cell Neurosci; 1994 Jun; 5(3):277-82. PubMed ID: 8087425
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mmip1: a novel leucine zipper protein that reverses the suppressive effects of Mad family members on c-myc.
    Gupta K; Anand G; Yin X; Grove L; Prochownik EV
    Oncogene; 1998 Mar; 16(9):1149-59. PubMed ID: 9528857
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.